Carlos Lahoz

443 total citations
14 papers, 353 citations indexed

About

Carlos Lahoz is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Carlos Lahoz has authored 14 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Carlos Lahoz's work include Alzheimer's disease research and treatments (3 papers), Lysosomal Storage Disorders Research (3 papers) and Neurological diseases and metabolism (2 papers). Carlos Lahoz is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Lysosomal Storage Disorders Research (3 papers) and Neurological diseases and metabolism (2 papers). Carlos Lahoz collaborates with scholars based in Spain, United States and Taiwan. Carlos Lahoz's co-authors include Ignácio F. Mata, Chin Song Lu, Matthew J. Farrer, Sarah Lincoln, Ruey‐Meei Wu, Jennifer M. Kachergus, Mary Hulihan, Julie P. Taylor, Stephanie A. Cobb and Jan Aasly and has published in prestigious journals such as The Journal of Immunology, Clinica Chimica Acta and Neuroscience Letters.

In The Last Decade

Carlos Lahoz

13 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos Lahoz Spain	8	201	127	111	94	73	14	353
Cecilia Huerta Spain	8	201 1.0×	71 0.6×	179 1.6×	105 1.1×	90 1.2×	8	382
Helen Latsoudis Greece	12	122 0.6×	84 0.7×	193 1.7×	65 0.7×	119 1.6×	27	413
Tatsunori Maekawa Japan	12	307 1.5×	138 1.1×	176 1.6×	110 1.2×	87 1.2×	18	420
Fai Tsang Singapore	10	180 0.9×	107 0.8×	149 1.3×	61 0.6×	87 1.2×	13	414
Carlos Lorenzana United States	4	112 0.6×	69 0.5×	184 1.7×	132 1.4×	50 0.7×	4	438
Sara A. Ferreira Denmark	7	268 1.3×	110 0.9×	115 1.0×	234 2.5×	158 2.2×	10	476
Chantal Maghames France	6	150 0.7×	166 1.3×	214 1.9×	73 0.8×	59 0.8×	7	433
Payal N. Gandhi United States	6	330 1.6×	122 1.0×	233 2.1×	79 0.8×	88 1.2×	6	456
Jasper Van Dongen Belgium	8	75 0.4×	198 1.6×	226 2.0×	153 1.6×	71 1.0×	11	512
Minjuan Bian China	11	97 0.5×	26 0.2×	162 1.5×	55 0.6×	123 1.7×	15	335

Countries citing papers authored by Carlos Lahoz

Since Specialization

Citations

This map shows the geographic impact of Carlos Lahoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Lahoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Lahoz more than expected).

Fields of papers citing papers by Carlos Lahoz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Lahoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Lahoz. The network helps show where Carlos Lahoz may publish in the future.

Co-authorship network of co-authors of Carlos Lahoz

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Lahoz. A scholar is included among the top collaborators of Carlos Lahoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Lahoz. Carlos Lahoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mostaza, José María, Carlos Lahoz, M. Castro, et al.. (2025). Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study. Revista Clínica Española (English Edition). 225(8). 502344–502344.

Frutos, Laura López de, Pilar Alfonso, Carlos Lahoz, Pilar Irún, & Pilar Giraldo. (2020). Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients. Medicina Clínica. 155(12). 529–534. 1 indexed citations

Frutos, Laura López de, et al.. (2020). Serum protein profile analysis in lysosomal storage disorders patients. Clinica Chimica Acta. 510. 430–436. 3 indexed citations

Frutos, Laura López de, Luis Aldámiz‐Echevarría, A. de la Vega, et al.. (2020). New variants in Spanish Niemann–Pick type c disease patients. Molecular Biology Reports. 47(3). 2085–2095. 5 indexed citations

Murías, Eduardo, et al.. (2012). Tratamiento endovascular de la estenosis carotídea: experiencia en el Hospital Universitario Central de Asturias. Revista de Neurología. 54(2). 93–93. 1 indexed citations

Fernández-Morera, Juan Luís, Sandra Rodríguez‐Rodero, Jesús Martı́nez-Borra, et al.. (2008). Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Tissue Antigens. 72(1). 54–59. 22 indexed citations

Álvarez, Victoria, Pelayo González, Ana I. Corao, et al.. (2008). The Sp1/Egr1-tandem Repeat Polymorphism in the 5-Lipoxygenase Gene Promoter is not Associated With Late Onset Alzheimer Disease. Alzheimer Disease & Associated Disorders. 22(2). 177–180. 9 indexed citations

Rodríguez‐Rodero, Sandra, Luı́s Rodrigo, Jesús Martı́nez-Borra, et al.. (2006). Clinical behavior of multiple sclerosis is modulated by the MHC class I‐chain‐related gene A. Tissue Antigens. 67(5). 409–414. 6 indexed citations

González, Pelayo, Victoria Álvarez, Manuel Menéndez‐González, et al.. (2006). Myocyte enhancing factor-2A in Alzheimer's disease: Genetic analysis and association with MEF2A-polymorphisms. Neuroscience Letters. 411(1). 47–51. 15 indexed citations

10.

Mata, Ignácio F., Jennifer M. Kachergus, Julie P. Taylor, et al.. (2005). Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics. 6(4). 171–177. 192 indexed citations

11.

Álvarez, Victoria, Ignácio F. Mata, Pelayo González, et al.. (2002). Association between the TNFα‐308 A/G polymorphism and the onset‐age of Alzheimer disease. American Journal of Medical Genetics. 114(5). 574–577. 57 indexed citations

12.

Álvarez, Victoria, et al.. (2001). Early-onset Parkinson’s disease associated with a new parkin mutation in a Spanish family. Neuroscience Letters. 313(1-2). 108–110. 16 indexed citations

13.

Andrés, Belén de, Victoria del Pozo, Blanca Cárdaba, et al.. (1991). Phosphoinositide breakdown is associated with Fc-gamma RII-mediated activation of 5’-lipoxygenase in murine eosinophils. The Journal of Immunology. 146(5). 1566–1570. 11 indexed citations

14.

Andrés, Belén de, Victoria del Pozo, Elena Martín‐Orozco, P. Palomino, & Carlos Lahoz. (1990). Release of O2- and LTC4 by murine eosinophils: role of intra- and extracellular calcium.. PubMed. 69(2). 271–6. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact